Identity & oversight
- Legal jurisdiction
- Registration or licensure
- Third-party oversight
- Primary-source document links
A record of verifiable attributes
Provider Comparison Matrix
Use this structured template to compare ibogaine providers through documents, direct statements, and clearly recorded unknowns—not star ratings. It is designed for investigative or editorial use and is not a treatment recommendation.
Every populated cell should identify what was checked, where it was found, and when the source was reviewed.
01 — Purpose
Compare evidence, not impressions.
A neutral matrix makes the basis for comparison visible. It separates a published document from a marketing assertion, an unanswered question from a confirmed absence, and a provider statement from third-party oversight. This approach complements the broader verification checklist for ibogaine treatment reviews by giving the same questions a repeatable structure.
“The matrix records what can be verified; it does not convert incomplete information into a recommendation.”
02 — Core fields
Start with mandatory columns.
Keep one row per provider and one source field for every attribute. Jurisdictional labels should be recorded exactly as presented in official records or direct materials. For orientation on how jurisdictions can differ, the U.S. Drug Enforcement Administration’s ibogaine factsheet identifies ibogaine as a Schedule I controlled substance in the United States.
Protocol evidence
- Product type and lab COA
- Documented ECG/QTc protocols
- Onsite emergency equipment or arrangements
- Formal screening criteria
Published disclosures
- Adverse-event data or disclaimers
- Aftercare plan details
- Published patient outcome studies
- Trial affiliations, when applicable
03 — Working template
A matrix built for traceability.
Use concise entries and preserve the evidentiary path. A field is stronger when a reviewer can open a document, locate the statement, and identify its date and scope. When cardiovascular monitoring is claimed, distinguish a general mention from a documented protocol; FDA safety communication on QT prolongation illustrates why a QTc-related claim should be treated as a specific safety-relevant detail, not a generic reassurance.
| Comparison field | What to record | Source requirement | Status convention |
|---|---|---|---|
| Legal jurisdiction | Country, state or region; entity name where documented. | Official registry, legal record, or direct statement with date. | Documented |
| Registration / licensure | Exact licence, registration, or authorization language; note scope. | Regulator record or source document, not a paraphrase alone. | Unknown if not verified |
| Product type & lab COA | Product description, batch specificity, and certificate availability. | COA or direct provider statement linked and dated. | Not published if no record |
| ECG / QTc protocol | Whether an actual written protocol is available; preserve quoted terms. | Protocol document or direct statement with reviewer note. | Documented |
| Emergency arrangements | Named equipment, onsite capacity, transfer arrangements, or disclosure. | Provider document or direct response retained verbatim. | Unknown if unanswered |
| Screening, events & aftercare | Formal criteria, adverse-event disclosure, and post-visit plan details. | Published policy, direct statement, or separately labelled absence. | Absent only when confirmed |
04 — Source discipline
Require a source for every cell.
Record the URL or document identifier, access date, document date when available, and a short note on what the source actually supports. A provider website can document what a provider states; it does not independently verify the claim. When a direct response is used, retain the wording and identify the date of the response.
For terminology, an overview of a certificate of analysis can help distinguish a laboratory document from a broad product assertion, while the matrix should still rely on the actual provider-linked record where one is available. The framework for reading reviews carefully can help keep anecdotal accounts separate from documentary evidence.
01
Locate. Prefer primary documents, regulator records, published policies, and attributable direct statements.
02
Quote. Capture the exact relevant language rather than broadening what the source says.
03
Label. Mark the result as documented, unknown, or absent under a stated rule.
05 — Transparency rules
Do not score clinical quality.
A transparency score, if used at all, should describe the availability and traceability of information—not safety, suitability, effectiveness, or treatment quality. The information tools and review methods used across this site are designed to keep those boundaries explicit.
Documented
- A relevant source is available and linked.
- The source supports the exact attribute entered.
- The record includes a review date and source type.
Unknown
- No adequate source was found in the documented review process.
- A statement is too vague to support the field.
- A requested clarification was unavailable or unanswered.
Absent
- Use only when a source directly establishes nonexistence.
- Do not infer absence from a missing webpage.
- Keep the confirming source alongside the entry.
Optional fields
- Published patient outcome studies may be listed with study limitations.
- Trial affiliations may be recorded with official registry links.
- Do not turn optional evidence into a star rating.
Clarifications
Questions the matrix should answer plainly.
These notes support consistent use of a comparison record. They do not provide medical or legal advice, and they do not determine whether any provider is appropriate for an individual.
What does unknown mean in a comparison matrix?
Unknown means no adequate verifiable source was located during the documented review process. It does not mean that an attribute is absent, unsafe, or unimportant; it means the matrix does not have enough evidence to enter a stronger conclusion.
Should a matrix recommend a provider?
No. The matrix is an informational record of documented attributes and source quality. It should not make treatment recommendations, clinical assessments, or implied rankings.
Which source should be used for each cell?
Use a primary document or direct provider statement whenever possible, retaining the source link, date reviewed, and a concise quotation or location note. If a third-party oversight body is relevant, record its original publication rather than relying on an unsourced summary.
Use with care
A transparent record is more useful than a confident-looking score.
Keep the matrix current, label its limits, and preserve the source trail. Its role is to make information easier to inspect—not to replace professional, legal, or medical judgment.